Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it.

A university professor and two students recreated a virus identical to the one that caused the devastating 1918 Spanish Flu ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

Prime Minister Narendra Modi on Thursday hailed the completion of the Genome India Project as a historic milestone in the ...